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Abstract
We have recently found that cannabinoid receptor binding and gene expression markedly decreased in extrapyramidal
structures of aged rats. The present study was designed to analyze the possible existence of similar aging-induced changes in
cannabinoid receptor binding and gene expression in brain regions other than extrapyramidal areas, but that also contain a
significant population of cannabinoid receptors, such as the cerebellum, hippocampal structures, limbic and hypothalamic
nuclei, the cerebral cortex and others. To this end, we analyzed cannabinoid receptor binding, using autoradiography, and
cannabinoid receptor mRNA levels, using in situ hybridization, in slide-mounted brain sections obtained from young (3
month old) and aged (s 2 year old) rats. Results were as follows. In the cerebellum, aged rats exhibited a marked decrease in
cannabinoid receptor binding in the molecular layer (333.3%), although accompanied by no changes in mRNA levels in the
granular layer. In the cerebral cortex, a small, although statistically significant, decrease in binding was found in the deep
layer (VI) (318.3%) of aged rats, whereas no changes were found in the superficial layer (I). As in the case of the cerebellum,
mRNA levels did not change in the cerebral cortex layers (II^III and V^VI). The different regions of the Ammon’s horn of
the hippocampus exhibited similar cannabinoid receptor binding levels in aged and young rats. Interestingly, mRNA levels
decreased in aged rats to a small, but statistically significant, extent (CA1: 326.1%; CA2: 321.6%; CA3: 314.4%). This was
also seen in another hippocampal structure, the dentate gyrus (314.6%), although in this region binding levels increased in
aged rats (+28.4%). Two hypothalamic structures, the arcuate nucleus and the ventromedial hypothalamic nucleus, exhibited
decreased cannabinoid receptor binding in aged rats (331.1% and 330.3%, respectively), but this was not seen in the medial
preoptic area. This was accompanied by no changes in mRNA levels in the ventromedial hypothalamic nucleus. In the limbic
structures, aged rats exhibited similar binding levels to young rats. This was seen in the nucleus accumbens, septum nuclei
and basolateral amygdaloid nucleus. However, mRNA levels slightly decreased in the basolateral amygdaloid nucleus
(313.4%), whereas they were not altered in the septum nuclei. Finally, other brain structures, such as the central gray
substance and the brainstem, exhibited similar binding levels in aged and young rats. However, it is important to note that
mRNA levels increased significantly (+211.2%) in the brainstem of aged rats, an area where the levels of binding and mRNA
were very low in young rats. This marked increase may be related to an increase in the presence of glial elements in this
region, as revealed by the increase in the immunoreactivity for glial fibrillary acidic protein observed in the brainstem of aged
rats as compared to young animals. In summary, senescence was associated with changes in cannabinoid receptors in the
cerebellum, the cerebral cortex, limbic and hypothalamic structures, the hippocampus and other brain regions. However, the
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changes observed (i) were not as marked and relevant as those early reported in extrapyramidal areas, and (ii) exhibited
regional differences that might be attributed to the different roles played by these receptors in each region. Of particular
relevance by their magnitude were the aging-induced decrease in binding found in the cerebellum and the hypothalamus, and
the increase in mRNA levels observed in the brainstem. The latter might be related to an increase in the presence of glial cells
which might contain cannabinoid receptor mRNA. ß 1998 Elsevier Science B.V. All rights reserved.
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1. Introduction
A great amount of literature has allowed to dem-
onstrate the existence of an endogenous cannabinoid
system (endogenous ligands+receptor signaling path-
ways), which might play a role in a variety of phys-
iological processes (for review, see [1,2]). It has been
proposed, based on the distribution of cannabinoid
receptor binding and mRNA levels in the brain [3^5]
and on the well-known pharmacological e¡ects of
plant and synthetic cannabinoids (for review, see
[6]), that the endogenous cannabinoid system would
be involved in the regulation of motor behavior, cog-
nition, learning and memory and antinociception, as
well as that it might play a role in brain development
[7,8].
Recent studies have demonstrated that cannabi-
noid receptor binding decreases in several brain re-
gions, mainly in extrapyramidal areas, in a variety of
neurodegenerative diseases, such as Huntington’s
chorea [9,10] or Alzheimer’s disease [11]. For in-
stance, cannabinoid receptors almost completely dis-
appeared in the substantia nigra [9], in the globus
pallidus (more markedly in the lateral part than in
the medial area) [10] and, to a lesser extent, in the
putamen [10] in Huntington’s disease. This motor
disorder is precisely characterized by a selective loss
of striatal e¡erent neurons [12], precisely those which
contain cannabinoid receptors in the extrapyramidal
circuitry [13]. Cannabinoid receptor binding also de-
creased in another neurodegenerative disorder, such
as the Alzheimer’s disease [11]. Thus, cannabinoid
receptor binding decreased in the hippocampus, cau-
date-putamen, medial globus pallidus and substantia
nigra pars reticulata, although always to a lesser ex-
tent than in Huntington’s chorea, whereas no
changes were seen in cannabinoid receptor mRNA
expression [11].
It is important to note that in the study from
Westlake et al. [11] on the changes in cannabinoid
receptors in the Alzheimer’s brains, the authors be-
lieved their results to be related more to an e¡ect of
increasing age rather than selectively associated with
the pathology characteristics of Alzheimer’s disease.
However, despite these data [11] and those obtained
in other neurodegenerative diseases [9,10], there is
scarce evidence in regard to potential changes of
these receptors during normal senescence. It would
be attractive if the synthesis, binding and/or func-
tionality of cannabinoid receptors in the brain might
be altered in aged individuals, as reported for the
receptors of other neurotransmitters [14^16], thus
suggesting their possible use as a molecular marker
in normal and pathological aging. In this sense, it is
interesting to note that the impairment of functions
associated with marihuana consumption, in terms of
psychomotor performance, immediate memory, mo-
tor coordination and others, declines with age [17]. It
is likely that these e¡ects associated with marihuana
exposure might be undoubtedly caused by the acti-
vation of cannabinoid receptors located in the brain
structures related to those neurobiological processes,
such as the basal ganglia, the hippocampus, the cer-
ebellum, the limbic nuclei and others, which present
measurable binding levels for these receptors [3,4].
In this sense, Belue et al. [18] have recently re-
ported that cannabinoid receptor binding did not
change during the normal aging process in rats, but
this study was quite limited since it was performed in
whole brain and using membrane binding techniques.
Previously, Mailleux and Vanderhaeghen [19] re-
ported a reduction in the expression of cannabinoid
receptors and mRNA levels in the striatum of aged
rats, although these authors did not examine other
brain areas. In a recent study, our group has found
that cannabinoid receptor binding and gene expres-
sion, measured by autoradiography and in situ hy-
bridization, respectively, markedly decreased in ex-
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trapyramidal structures of aged rats [20]. We have
found a selective aging-induced reduction in canna-
binoid receptors located in striatonigral and stria-
toentopeduncular neurons, but a maintenance in
striatopallidal neurons [20], all accounting for the
progressive motor impairment characteristic of nor-
mal senescence. However, in our previous study [20],
only extrapyramidal areas were examined and noth-
ing was reported about other regions that are rele-
vant from the view of an important presence of can-
nabinoid receptors, such as the hippocampus,
cerebellum, limbic structures, cerebral cortex and
others. The present study was designed to determine
the possible existence of aging-induced changes in
cannabinoid receptor binding and gene expression
in brain regions other than extrapyramidal struc-
tures. To this end, we analyzed, using autoradiogra-
phy with [3H]WIN 55,212-2, the speci¢c binding of
cannabinoid receptors in slide-mounted brain sec-
tions obtained from young (3 month old) and aged
(s 2 year old) rats. This experiment was completed
with the analysis of cannabinoid receptor mRNA
levels, using in situ hybridization, in slide-mounted
brain sections also obtained from young and aged
rats. Finally, we also analyzed glial ¢brillary acidic
protein (GFAP) immunoreactivity in brain sections
of young and aged rats that contain the brainstem.
The speci¢c objective of this study was to demon-
strate that the high presence of cannabinoid receptor
mRNA levels in this area in aged rats might be re-
lated to an increase in the presence of glial cells in
senescence.
2. Materials and methods
2.1. Animals, sampling and tissue preparation
Two age groups of male Wistar rats were used in
this study: young rats (3 months old) and aged rats
(s 2 years old). They were housed in a room with
controlled photoperiod (08.00^20.00 h light) and
temperature (23 þ 1‡C). They had free access to
standard food and water. At the two ages described
above, young and aged rats were used for two di¡er-
ent experiments. In the ¢rst experiment, animals were
sacri¢ced by rapid decapitation and their brains
quickly and carefully removed and rapidly frozen
by immersion in 2-methylbutane cold in dry ice
(T =330‡C). All samples were stored at 370‡C until
processed. Coronal sections 20 Wm thick were cut in
a cryostat, according to the atlas of Paxinos and
Watson [21]. Sections were thaw-mounted onto
RNase-free gelatin/chrome alum coated slides and
dried brie£y at 30‡C and stored at 380‡C until
use. For the identi¢cation of the di¡erent brain nu-
clei, adjacent sections to those used for autoradio-
graphic analysis were stained with cresyl violet and
analyzed according to the atlas of Paxinos and Wat-
son [21]. Sections from six di¡erent animals per
group were used for each of the two autoradio-
graphic analyses. In the second experiment, animals
were anesthetized with ether and perfused transcar-
dially with 2.5% paraformaldehyde in phosphate buf-
fer (pH 7.2). The brains were dissected and post¢xed
in the same ¢xative for 4 h at 4‡C. Tissue blocks
were dehydrated and embedded in para⁄n. Adjacent
sections of 8 Wm thick were processed for immuno-
detection of GFAP.
2.2. Autoradiography of cannabinoid receptor binding
The protocol used is basically the method de-
scribed by Jansen et al. [22] with modi¢cations.
Brie£y, slide-mounted brain sections were preincu-
bated for 20 min, at 30‡C, in a bu¡er containing
20 mM HEPES with 0.5% bovine serum albumin
(fatty acid-free), pH 7.0. Slides were then incubated
for 80 min, at 30‡C, with 1 nM [3H]WIN 55,212-2
(Du Pont NEN, Itisa, Madrid, Spain) prepared in
the same bu¡er, in the absence or the presence of
10 WM unlabeled WIN 55,212-2 (RBI, Natick, MA,
USA) to determine total and non-speci¢c binding,
respectively. Following this incubation, slides were
washed in bu¡er four times (10 min each) at room
temperature, dipped in ice-cold distilled water and
then dried under a stream of cool dried air. Auto-
radiograms were generated by apposing the labeled
tissues, together with autoradiographic standards
([3H]-micro-scales, Amersham Ibe¤rica, Madrid,
Spain), to tritium-sensitive ¢lm ([3H]-Hyper¢lm,
Amersham Ibe¤rica) for a period of 3^4 weeks, and
developed (D-19, Kodak) for 4 min at 20‡C. Devel-
oped ¢lms were analyzed and quantitated in a com-
puter-assisted videodensitometer (Image Quant 3.3,
Molecular Dynamics) using the standard curve gen-
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erated from [3H] standards. After logarithmic trans-
formation, all data were best ¢tted to a linear equa-
tion.
2.3. Analysis of cannabinoid receptor mRNA levels by
in situ hybridization
In situ hybridization was carried out according to
the procedure previously described by Rubino et al.
[23] with slight modi¢cations. Brie£y, sections were
¢xed in 4% formaldehyde for 5 min and, after rinsing
twice in phosphate bu¡er saline, acetylated by incu-
bation in 0.25% acetic anhydride, prepared in 0.1 M
triethanolamine/0.15 M sodium chloride (pH 8.0),
for 10 min. Sections were rinsed in 0.3 M sodium
chloride/0.03 M sodium citrate (pH 7.0), dehydrated
and delipidated by ethanol/chloroform series. A mix-
ture (1:1:1) of the three 48-mer oligonucleotide
probes complementary to bases 4^51, 349^396 and
952^999 of the rat cannabinoid receptor cDNA
(Du Pont, Itisa; the speci¢city of the probes used
was assessed by Northern blot analysis, data not
shown) was 3P-end labeled with [35S]dATP (Amer-
sham Ibe¤rica) using terminal deoxynucleotidyl trans-
ferase (Boehringer Mannheim, Barcelona, Spain).
Sections were then hybridized with 35S-labeled oligo-
nucleotide probes (2.5U105 dpm per section),
washed and exposed to X-ray ¢lm (Lmax, Amersham
Ibe¤rica) for 10 days, and developed (D-19, Kodak)
for 6 min at 20‡C. The intensity of the hybridization
signal was assessed by measuring the grey levels in
the autoradiographic ¢lms with a computer-assisted
videodensitometer (Image Quant 3.3, Molecular Dy-
namics). Additional brain sections were co-hybri-
dized with a 100-fold excess of cold probe or with
RNAse to assert the speci¢city of the signal. As ex-
pected, no hybridization signal was detected in these
sections (data not shown).
2.4. Immunohistochemical analysis of GFAP
Sections were depara⁄ned and treated with non-
Table 1
Cannabinoid receptor binding (fmol/mg tissue) measured by autoradiography in several brain areas of young (3 months) and aged
(s 2 years) male rats
Brain region Cannabinoid receptor binding (fmol/mg tissue)
Young rats Aged rats Change (%)
Hippocampus
Ammon’s horn
CA1 104.7 þ 3.6 95.8 þ 8.9 38.5
CA2 98.1 þ 4.2 95.4 þ 6.5 32.8
CA3 68.3 þ 3.2 67.8 þ 6.0 30.7
Dentate gyrus 72.1 þ 4.4 92.6 þ 7.1* +28.4
Cerebral cortex
Super¢cial layer (I) 78.7 þ 6.9 77.0 þ 5.1 32.2
Deep layer (VI) 70.1 þ 3.8 57.3 þ 4.9* 318.3
Cerebellum
Molecular layer 185.7 þ 11.7 124.1 þ 15.7** 333.3
Limbic nuclei
Nucleus accumbens 53.1 þ 4.5 55.6 þ 6.8 +4.7
Septum nuclei 53.4 þ 8.1 51.1 þ 5.7 34.3
Basolateral amygdaloid nuclei 29.9 þ 3.3 29.8 þ 3.7 30.3
Hypothalamus
Arcuate nucleus 19.6 þ 2.0 13.5 þ 2.5* 331.1
Ventromedial hypothalamic nucleus 21.1 þ 2.5 14.7 þ 1.3* 330.3
Medial preoptic area 17.0 þ 1.4 14.3 þ 3.5 315.9
Miscellaneous
Central gray substance 19.6 þ 2.6 17.5 þ 2.2 310.7
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immune serum diluted 1/30 in Tris bu¡er (pH 7.6)
for 30 min. Slides were incubated in polyclonal
GFAP antiserum (Dakopatts), diluted 1/1000 in
Tris bu¡er for 24 h at 4‡C. Following three 5 min
washes in Tris bu¡er, sections were incubated in
swine anti-rabbit IgG, diluted 1/50 for 1 h at 20‡C,
washed in Tris bu¡er and incubated in rabbit PAP
complex, diluted 1/200, for 1 h at 20‡C. Thereafter,
sections were rinsed twice in Tris bu¡er and the per-
oxidase activity was demonstrated with 0.03% DAB
(Sigma, Madrid, Spain) in 0.05 M Tris bu¡er with
0.005% H2O2, washed in distilled water, dehydrated
in graded concentrations of ethanol and mounted in
DePeX. Some sections were incubated with preim-
mune swine serum at 1/30 dilution as the primary
antiserum. These control sections showed no immu-
noreactive product.
2.5. Statistics
Autoradiographic data of cannabinoid receptor
binding and mRNA levels in young and aged rats
were assessed by Student’s t-test.
3. Results
3.1. Cerebellum
Aged rats exhibited a marked decrease in cannabi-
noid receptor binding in the molecular layer
(333.3%; see Table 1), although not accompanied
by changes in mRNA levels in the granular layer
(Table 2). See representative autoradiograms for
both binding and mRNA levels in Figs. 1 and 2.
3.2. Cerebral cortex
A small, although statistically signi¢cant, decrease
in cannabinoid receptor binding was found in the
deep layer (VI) of the cerebral cortex (318.3%)
of aged rats, whereas no changes were found in
the super¢cial layer (I) (Table 1). As in the case of
the cerebellum, cannabinoid receptor mRNA levels
did not change in the cerebral cortex layers (II^III
and V^VI) (Table 2). See representative autoradio-
grams for both binding and mRNA levels in Figs. 1
and 2.
Table 2
Cannabinoid receptor mRNA levels (expressed as arbitrary units of optical density) measured by in situ hybridization in several brain
areas of young (3 months) and aged (s 2 years) male rats
Brain region Optical density (arbitrary units)
Young rats Aged rats Change (%)
Hippocampus
Ammon’s horn
CA1 0.337 þ 0.034 0.249 þ 0.013* 326.1
CA2 0.399 þ 0.040 0.313 þ 0.018* 321.6
CA3 0.416 þ 0.019 0.356 þ 0.019* 314.4
Dentate gyrus 0.411 þ 0.010 0.351 þ 0.015** 314.6
Cerebral cortex
Layers II^III 0.228 þ 0.017 0.255 þ 0.016 +11.8
Layers V^VI 0.235 þ 0.013 0.239 þ 0.008 +1.7
Cerebellum
Granular layer 0.884 þ 0.047 0.960 þ 0.080 +8.6
Limbic nuclei
Septum nuclei 0.156 þ 0.014 0.179 þ 0.005 +14.7
Basolateral amygdaloid nuclei 0.352 þ 0.019 0.305 þ 0.013* 313.4
Hypothalamus
Ventromedial hypothalamic nucleus 0.333 þ 0.025 0.322 þ 0.022 33.3
Miscellaneous
Brainstem 0.178 þ 0.026 0.554 þ 0.140** +2-
11
.2
Values are expressed as means þ S.E.M. of six animals per group. Data were analyzed by Student’s t-test.
*P6 0.05.
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3.3. Hippocampus
The di¡erent regions of the Ammon’s horn of the
hippocampus exhibited similar cannabinoid receptor
binding levels in aged and young rats (Table 1). In-
terestingly, cannabinoid receptor mRNA levels de-
creased in aged rats to a small, but statistically sig-
ni¢cant, extent (CA1: 326.1%; CA2: 321.6%;
CA3: 314.4%; see Table 2). This was also seen in
another hippocampal structure, the dentate gyrus
(314.6%; see Table 2), although in this region, can-
nabinoid receptor binding slightly increased in aged
rats (+28.4%; see Table 1). See representative auto-
radiograms for both binding and mRNA levels in
Figs. 1 and 2.
3.4. Hypothalamus
Two hypothalamic structures, the arcuate nucleus
and the ventromedial hypothalamic nucleus, exhib-
ited decreased cannabinoid receptor binding in aged
rats (331.1% and 330.3%, respectively; see Table 1),
but this was not seen in the medial preoptic area
(Table 1). This was not accompanied by changes in
mRNA levels in the ventromedial hypothalamic nu-
cleus (Table 2). See representative autoradiograms
for both binding and mRNA levels in Figs. 1 and 2.
3.5. Limbic structures
Aged rats exhibited similar cannabinoid receptor
binding levels as young rats (Table 1). This was
seen in the nucleus accumbens as well as in the baso-
lateral amygdaloid nucleus and septum nuclei. How-
ever, mRNA levels slightly decreased in the basolat-
eral amygdaloid nucleus (313.4%), whereas they
were not altered in the septum nuclei (Table 2). See
representative autoradiograms for both binding and
mRNA levels in Figs. 1 and 2.
3.6. Miscellaneous
We also analyzed other brain structures, all con-
taining very low levels of cannabinoid receptor bind-
ing and mRNA, such as the central gray substance
and the brainstem. Cannabinoid receptor binding
levels were similar in the central gray substance of
aged and young rats (Table 1), whereas mRNA levels
were practically non-detectable. Contrarily, cannabi-
noid receptor binding levels were practically similar
Fig. 1. Representative autoradiograms (5U) for cannabinoid receptor binding at the level of plates 28 and 68 according to the atlas
of Paxinos and Watson [21], obtained from slide-mounted brain sections of young (3 months; left panels) and aged (s 2 years; mid-
dle panels) male rats. Right panels correspond to non-speci¢c binding in the sections of young rats (similar autoradiograms were ob-
tained for the non-speci¢c binding in aged rats). Autoradiograms were processed according to the conditions described in Section 2.
1, super¢cial layers of the cerebral cortex; 2, deep layers of the cerebral cortex; 3, Ammon’s horn; 4, dentate gyrus; 5, molecular
layer of the cerebellum; 6, brainstem.
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to non-speci¢c binding in the brainstem of both
young and aged rats, whereas mRNA levels were
detectable and increased signi¢cantly (+211.2%) in
aged rats (Table 2). See representative autoradio-
grams for both binding and mRNA levels in Figs.
1 and 2. This increase runs in parallel to an increase
in GFAP immunoreactivity observed in the brain-
stem of aged rats as compared to young animals
(see Fig. 2). This might indicate that the high levels
for cannabinoid receptor mRNA in this area might
be located in glial cells, particularly astrocytes.
4. Discussion
In our previous study [20], we have seen that aging
produces a marked drop in cannabinoid receptor
binding and mRNA expression in extrapyramidal
structures. This might be related to the decrease in
these receptors observed in several neurodegenerative
diseases a¡ecting the basal ganglia such as the Hun-
tington’s chorea [9,10]. In the same line, Westlake et
al. [11] analyzed the changes in cannabinoid recep-
tors in Alzheimer’s brains and concluded that these
changes were mainly observed in the basal ganglia
and were related more to an e¡ect of increasing
age rather than selectively associated with the path-
ology characteristics of Alzheimer’s disease. In the
present study, we have seen that the changes found
in the basal ganglia of aged rats [20] were also ob-
served in brain regions other than extrapyramidal
areas, although these changes were mostly less
Fig. 2. Representative autoradiograms for cannabinoid receptor mRNA levels (top and middle panels; 5U) and photomicrographs for
GFAP immunoreactivity (bottom panels; 450U) at the level of plates 28 and 68 according to the atlos of Paxinos and Watson [21],
obtained from slide-mounted brain sections of young (3 months; left panels) and aged (s 2 years; right panels) male rats. Autoradio-
grams and photomicrographs were processed according to the conditions described in Section 2. 1, super¢cial layers of the cerebral
cortex; 2, deep layers of the cerebral cortex; 3, Ammon’s horn; 4, dentate gyrus; 5, ventromedial hypothalamic nucleus; 6, basolateral
amygdaloid nucleus; 7, granular layer of the cerebellum; 8, brainstem; arrow, GFAP-positive cells.
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marked. Moreover, the changes observed showed re-
gional di¡erences that possibly indicate a selective
alteration of cannabinoid receptor-containing neu-
rons in the di¡erent areas.
There was a marked decrease in cannabinoid re-
ceptor binding in the molecular layer of the cerebel-
lum of aged rats. However, as a di¡erence versus
extrapyramidal structures [20], the levels of gene
transcripts were not altered in the granular layer,
the layer where most of the cell bodies of cannabi-
noid receptor-containing neurons in the cerebellum
are clustered [5]. This decrease, only observed in re-
ceptor binding, might indicate that axonal terminals
in the molecular layer, those containing cannabinoid
receptors, may be a¡ected earlier or more severely
than their cell bodies or dendrites in the granular
layer, as suggested by Rich¢eld and Herkenham
[10] in the globus pallidus of Huntington’s brains.
Alternatively, it might be considered that this di¡er-
ence, decreases in binding and no changes in gene
expression, might re£ect an impairment preferentially
associated with de¢cient production, processing or
transport of cannabinoid receptors to axonal termi-
nals. An unlikely possibility would be that the de-
crease in binding might re£ect the aging-induced
death of neurons containing these receptors, because,
in that case, a similar decrease in gene transcripts
should be expected.
Decreases in binding and no changes in gene ex-
pression were also seen in other structures, and sim-
ilar explanations of the possible mechanisms in-
volved may be applied to these structures. Among
them, we could mention the deep layers of the cere-
bral cortex and the arcuate and ventromedial nuclei
of the hypothalamus. The changes in the cerebral
cortex were very small, although statistically signi¢-
cant, and only observed in the deep layers, likely
indicating a probably limited physiological relevance.
However, the changes in binding observed in the two
hypothalamic nuclei were more marked (more than
30% decrease), although, as in the case of the cere-
bellum, they were not accompanied by changes in
mRNA levels in one of these two nuclei, the ventro-
medial nucleus, where cell bodies of cannabinoid re-
ceptor-containing hypothalamic neurons have been
reported to be located [5].
In other structures, however, the changes observed
during senescence mainly a¡ected gene expression,
but not binding levels. This was the case in the di¡er-
ent sub¢elds of the Ammon’s horn of the hippocam-
pus, an area where cannabinoid receptors have been
reported to be located on both intrinsic and extrinsic
neurons [5]. Thus, mRNA levels slightly decreased,
but in a statistical signi¢cant manner, in the CA1,
CA2 and CA3 layers, with no changes in binding. In
our opinion, this might be interpreted as an aging-
induced primary reduction in receptor synthesis due
to a decrease in gene expression and/or in mRNA
stability, but the small magnitude of the decrease
appears to be not enough to originate a parallel
loss in binding capability. It would be possible that
the aging-induced decrease in gene expression,
although not a¡ecting the basal levels of receptor
binding, might originate a plausible de¢cit of these
neurons to respond to a variety of circumstances that
demand the de novo synthesis of receptors. A similar
kind of aging-induced alterations, decreases in gene
expression and no changes in binding, was seen in
the basolateral amygdaloid nucleus, and similar ex-
planations of possible mechanisms and physiological
relevance may be applied to this structure. In another
hippocampal structure, the dentate gyrus, mRNA
levels also decreased in aged rats, but in this case
the levels of speci¢c binding increased, which might
indicate the existence of a di¡erential e¡ect of aging
on cannabinoid receptor-containing neurons in this
region: decreased receptor synthesis, but increased
receptor binding capability. Further research should
provide additional evidence on this paradoxical re-
sult.
Finally, it is noteworthy to mention the case of the
brainstem. This area contains a relatively low popu-
lation of cannabinoid receptors. The levels of binding
measured by other authors were very low [3^5], and
in our present study practically non-existent since
they were scarcely di¡erent from background. How-
ever, the levels of gene transcripts, which have been
previously reported to be also very low in adult ani-
mals [5], markedly increased (more than 3-fold high-
er) in aged rats. There was no speci¢c location of this
increase in speci¢c areas of the brainstem, although it
might be appreciated higher grey levels in the areas
of raphe nuclei and reticulo-tegmental formation,
where the cell bodies of monoaminergic neurons
are located. These neurons, which do not contain
cannabinoid receptors in adult individuals, project
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to most of the forebrain structures. However, we
have found no increases in cannabinoid receptor
binding in the forebrain structures, which precludes
the possibility that cannabinoid receptors might be
signi¢cantly expressed during aging in these neurons.
An attractive possibility would be that the marked
increase found in mRNA levels in the brainstem of
aged rats might be related to the expression of can-
nabinoid receptors in non-neuronal elements, such as
glial cells. This would be similar to what occurs in
the developing brain where transient expression of
these receptors in glial cells has been proposed
[8,25^27]. It has been reported that the neuronal
death that appears during normal and pathological
aging is also associated with the appearance of glial
elements that replace dead neurons [24]. In support
of this hypothesis, we can argue that the magnitude
of the increase in mRNA levels in the brainstem
found in this study varied signi¢cantly in the aged
rat group, with most of the animals exhibiting higher
levels, but a few having levels similar to young rats.
It would be possible that the increase in mRNA lev-
els might run in parallel to the degree of neuronal
death and glial cell replacement. In the present study,
we have tried to validate this hypothesis by examin-
ing the immunoreactivity for GFAP, which is a
marker of astrocytes, in the same regions of the
brainstem where cannabinoid receptor mRNA levels
increased in aged rats. Our results con¢rmed that an
increased immunoreactivity for GFAP exists in the
brainstem of aged rats as compared to young ani-
mals. This increase was originated by both an in-
creased number of GFAP-positive neurons and in-
creased immunoreactivity for GFAP in each
individual cell.
In summary, senescence was associated with
changes in cannabinoid receptors in the cerebellum,
the cerebral cortex, limbic and hypothalamic struc-
tures, the hippocampus and other brain regions.
However, the changes observed (i) were not as
marked and relevant as those early reported in ex-
trapyramidal areas [20], and (ii) exhibited regional
di¡erences that might be attributed to the di¡erent
roles played by these receptors in each region. Of
particular relevance by their magnitude were the
aging-induced decrease in cannabinoid receptor bind-
ing found in the cerebellum and the hypothalamus,
and, in particular, the increase in mRNA levels ob-
served in the brainstem. It appears feasible that the
increase observed in the brainstem of aged rats might
re£ect the expression of this gene in glial cells, whose
number increased signi¢cantly in this region in sen-
escence.
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